A Pilot Trial of Cisplatin/Etoposide/Radiotherapy Followed by Consolidation Docetaxel and the Combination of Bevacizumab (NSC-704865) in Patients With Inoperable Locally Advanced Stage III Non–Small-Cell Lung Cancer: SWOG S0533-Reference-Cited by-同舟云学术

A Pilot Trial of Cisplatin/Etoposide/Radiotherapy Followed by Consolidation Docetaxel and the Combination of Bevacizumab (NSC-704865) in Patients With Inoperable Locally Advanced Stage III Non–Small-Cell Lung Cancer: SWOG S0533

Published:2015-09 Issue:5 Volume:16 Page:340-347
ISSN:1525-7304
Container-title:Clinical Lung Cancer
language:en
Short-container-title:Clinical Lung Cancer

Author:

Wozniak Antoinette J.,Moon James,Thomas Charles R.,Kelly Karen,Mack Philip C.,Gaspar Laurie E.,Raben David,Fitzgerald Thomas J.,Pandya Kishan J.,Gandara David R.

Publisher

Elsevier BV

Subject

Cancer Research,Pulmonary and Respiratory Medicine,Oncology

Reference27 articles.

1. Phase III study of concurrent versus sequential thoracic radiotherapy in combination with mitomycin, vindesine, and cisplatin in unresectable stage III non–small-cell lung cancer;Furuse;J Clin Oncol,1999

2. Sequential vs. concurrent chemoradiation for stage III non–small-cell lung cancer: randomized phase III RTOG 9410;Curran;J Natl Cancer Inst,2011

3. Concurrent cisplatin, etoposide plus radiotherapy for pathologic stage IIIB non–small-cell lung cancer: a Southwest Oncology Group phase II study (S9019);Albain;J Clin Oncol,2002

4. Consolidation docetaxel after concurrent chemoradiotherapy in stage IIIB non–small-cell lung cancer: phase II Southwest Oncology Group study S9504;Gandara;J Clin Oncol,2003

5. Long-term survival with concurrent chemoradiation therapy followed by consolidation docetaxel in stage IIIB non–small-cell lung cancer: a phase II Southwest Oncology Group study (S9504);Gandara;Clin Lung Cancer,2006

Cited by 41 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Palliative Thoracic Radiotherapy in the Era of Modern Cancer Care for NSCLC;Cancers;2024-08-29

2. Modeling of chemo-radiotherapy targeting growing vascular tumors: a continuum-level approach;2024-03-27

3. Redetermination of PD-L1 expression after chemio-radiation in locally advanced PDL1 negative NSCLC patients: retrospective multicentric analysis;Frontiers in Oncology;2024-01-31

4. A pilot trial of consolidation bevacizumab after hypo‐fractionated concurrent chemoradiotherapy in patients with unresectable locally advanced non‐squamous non‐small‐cell lung cancer;Cancer Medicine;2023-08-03

5. Radionecrosis mimicking pseudo‑progression in a patient with lung cancer and brain metastasis following the combination of anti‑PD‑1 therapy and stereotactic radiosurgery: A case report;Oncology Letters;2023-07-06